Replies to post #394469 on Elite Pharmaceuticals Inc (ELTP)

[JamesF1]

Nasrat will not over promote generic OxyContin if Elite’s product gets approved. There will certainly be a REMS (risk evaluation) in place for prescribers. Playing by all the rules there is still money to be made. Sadly, there are patients that have legitimate need.